Citation: W. Feleszko et al., RE - GRAYING OF AMERICA WILL FOSTER NEW STRATEGIES IN ONCOLOGY, Journal of the National Cancer Institute, 90(3), 1998, pp. 247-248
Authors:
GOLAB J
STOKLOSA T
ZAGOZDZON R
KACA A
KULCHITSKA LA
FELESZKO W
KAWIAK J
HOSER G
GLOWACKA E
DABROWSKA A
GIERMASZ A
LASEK W
JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR POTENTIATES ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 IN MELANOMA MODEL IN MICE, Tumor biology, 19(2), 1998, pp. 77-87
Authors:
FELESZKO W
ZAGOZDZON R
GOLAB J
JAKOBISIAK M
Citation: W. Feleszko et al., POTENTIATED ANTITUMOR EFFECTS OF CISPLATIN AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE, European journal of cancer, 34(3), 1998, pp. 406-411
Authors:
GOLAB J
STOKLOSA T
ZAGOZDZON R
KACA A
GIERMASZ A
POJDA Z
MACHAJ E
DABROWSKA A
FELESZKO W
LASEK W
IWANOSIECKA A
JAKOBISIAK M
Citation: J. Golab et al., G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE, Annals of oncology, 9(1), 1998, pp. 63-69
Authors:
GOLAB J
ZAGOZDZON R
STOKLOSA T
KACA A
DABROWSKA A
GIERMASZ A
FELESZKO W
JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-COLONY-STIMULATING FACTOR DEMONSTRATES ANTITUMOR-ACTIVITYIN MELANOMA MODEL IN MICE, Neoplasma, 45(1), 1998, pp. 35-39
Authors:
ZAGOZDZON R
GOLAB J
STOKLOSA T
GIERMASZ A
NOWICKA D
FELESZKO W
LASEK W
JAKOBISIAK M
Citation: R. Zagozdzon et al., EFFECTIVE CHEMOIMMUNOTHERAPY OF L1210 LEUKEMIA IN-VIVO USING INTERLEUKIN-12 COMBINED WITH DOXORUBICIN BUT NOT WITH CYCLOPHOSPHAMIDE, PACLITAXEL OR CISPLATIN, International journal of cancer, 77(5), 1998, pp. 720-727
Authors:
LASEK W
FELESZKO W
GOLAB J
STOKLOSA T
MARCZAK M
DABROWSKA A
MALEJCZYK M
JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, European journal of cancer, 33, 1997, pp. 22-22
Authors:
LASEK W
FELESZKO W
GOLAB J
STOKLOSA T
MARCZAK M
DABROWSKA A
MALEJCZYK M
JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 100-108
Authors:
FELESZKO W
GIERMASZ A
GOLATB J
LASEK W
KUC K
SZPERL M
JAKOBISIAK M
Citation: W. Feleszko et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ACCELERATES GROWTH OF LEWIS-LUNG-CARCINOMA IN MICE, Cancer letters, 101(2), 1996, pp. 193-197
Authors:
LASEK W
WANKOWICZ A
KUC K
FELESZKO W
GIERMASZ A
JAKOBISIAK M
Citation: W. Lasek et al., AUGMENTATION OF ANTITUMOR EFFICACY BY THE COMBINATION OF ACTINOMYCIN-D WITH TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA ON A MELANOMA MODEL IN MICE, Oncology, 53(1), 1996, pp. 31-37
Authors:
LASEK W
GIERMASZ A
KUC K
WANKOWICZ A
FELESZKO W
GOLAB J
ZAGOZDZON R
STOKLOSA T
JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF THE ANTITUMOR EFFECT OF ACTINOMYCIN-D BY TUMOR-NECROSIS-FACTOR-ALPHA IN MICE - CORRELATION BETWEEN IN-VITRO AND IN-VIVO RESULTS, International journal of cancer, 66(3), 1996, pp. 374-379
Authors:
LASEK W
WANKOWICZ A
KUC K
FELESZKO W
GOLAB J
GIERMASZ A
WIKTORJEDRZEJCZAK W
JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY MACROPHAGE-COLONY-STIMULATING FACTOR IN A MMB16 MELANOMA MODEL IN MICE, Cancer immunology and immunotherapy, 40(5), 1995, pp. 315-321
Citation: W. Feleszko et al., SYNERGISTIC ANTITUMOR-ACTIVITY OF TUMOR-NECROSIS-FACTOR-ALPHA AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE, Neoplasma, 42(2), 1995, pp. 69-74